Adicet Bio, Inc. — Director's Dealing 2024

Aug 20, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2024-08-19

Reporting Person: Klickstein Lloyd (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	102666	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$2.14	2031-01-12	Common Stock (80000)		Direct

Footnotes

F1: 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of January 13, 2021, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates.

F2: On August 8, 2023, the Issuer's Board of Directors approved an option repricing, effective as of August 14, 2023 (the "Repricing Effective Date"). All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. The exercise price of the option is $2.14 per share, representing the fair market value per share of the Issuer's Common Stock on the Repricing Effective Date.